Payment overview · 2025
General Payments
$35.58
2 reported records · 2 companies
Healthcare provider profile · identity verified
Tilak Raj Sharma, MD
Allopathic & Osteopathic Physicians|Internal Medicine · MCALESTER, OK · NPI 1720500945
Verified facts
What the public records show
CMS Open Payments records show Tilak Raj Sharma, MD received $35.58 in general payments during 2025 across 2 reported records.
Abbott Laboratories accounted for 55.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $19.72 | 55.4% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $15.86 | 44.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $35.58 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $19.72 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $15.86 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 427 | 78 |
| Atorvastatin Calcium | Atorvastatin Calcium | 420 | 135 |
| Levothyroxine Sodium | Levothyroxine Sodium | 369 | 110 |
| Lisinopril | Lisinopril | 352 | 107 |
| Amlodipine Besylate | Amlodipine Besylate | 343 | 112 |
| Pantoprazole Sodium | Pantoprazole Sodium | 310 | 107 |
| Gabapentin | Gabapentin | 274 | 66 |
| Losartan Potassium | Losartan Potassium | 258 | 85 |
| Omeprazole | Omeprazole | 240 | 83 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 221 | 69 |
| Metformin Hcl | Metformin Hcl | 203 | 68 |
| Hydrochlorothiazide | Hydrochlorothiazide | 201 | 57 |
| Metoprolol Succinate | Metoprolol Succinate | 189 | 60 |
| Fluticasone Propionate | Fluticasone Propionate | 174 | 72 |
| Furosemide | Furosemide | 172 | 67 |
| Montelukast Sodium | Montelukast Sodium | 170 | 49 |
| Tramadol Hcl | Tramadol Hcl | 169 | 37 |
| Tamsulosin Hcl | Tamsulosin Hcl | 162 | 59 |
| Duloxetine Hcl | Duloxetine Hcl | 156 | 51 |
| Potassium Chloride | Potassium Chloride | 155 | 58 |
| Trazodone Hcl | Trazodone Hcl | 140 | 42 |
| Carvedilol | Carvedilol | 136 | 46 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 135 | 56 |
| Metoprolol Tartrate | Metoprolol Tartrate | 128 | 46 |
| Clopidogrel | Clopidogrel Bisulfate | 122 | 43 |
| Simvastatin | Simvastatin | 118 | 39 |
| Sertraline Hcl | Sertraline Hcl | 116 | 36 |
| Celecoxib | Celecoxib | 115 | 34 |
| Ozempic | Semaglutide | 115 | 25 |
| Eliquis | Apixaban | 105 | 24 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 103 | 25 |
| Meloxicam | Meloxicam | 99 | 39 |
| Finasteride | Finasteride | 96 | 32 |
| Cephalexin | Cephalexin | 89 | 46 |
| Mirtazapine | Mirtazapine | 89 | 29 |
| Jardiance | Empagliflozin | 87 | 23 |
| Azithromycin | Azithromycin | 86 | 60 |
| Pravastatin Sodium | Pravastatin Sodium | 85 | 28 |
| Doxycycline Hyclate | Doxycycline Hyclate | 80 | 50 |
| Famotidine | Famotidine | 75 | 37 |
| Pregabalin | Pregabalin | 72 | 16 |
| Ezetimibe | Ezetimibe | 71 | 30 |
| Alprazolam | Alprazolam | 69 | 16 |
| Methylprednisolone | Methylprednisolone | 68 | 51 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 68 | 38 |
| Buspirone Hcl | Buspirone Hcl | 65 | 27 |
| Fluconazole | Fluconazole | 65 | 21 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 63 | 22 |
| Zolpidem Tartrate | Zolpidem Tartrate | 62 | 14 |
| Fluoxetine Hcl | Fluoxetine Hcl | 61 | 15 |
| Alendronate Sodium | Alendronate Sodium | 58 | 21 |
| Breo Ellipta | Fluticasone/Vilanterol | 57 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 57 | 18 |
| Estradiol | Estradiol | 57 | 18 |
| Quetiapine Fumarate | Quetiapine Fumarate | 57 | 12 |
| Allopurinol | Allopurinol | 56 | 19 |
| Ondansetron Odt | Ondansetron | 55 | 32 |
| Prednisone | Prednisone | 54 | 25 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 53 | 22 |
| Temazepam | Temazepam | 51 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 50 | 15 |
| Glipizide | Glipizide | 50 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 48 | 17 |
| Naproxen | Naproxen | 45 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 44 | 15 |
| Rybelsus | Semaglutide | 43 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 43 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 42 | 16 |
| Doxazosin Mesylate | Doxazosin Mesylate | 42 | 13 |
| Farxiga | Dapagliflozin Propanediol | 42 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 42 | suppressed |
| Spironolactone | Spironolactone | 41 | 18 |
| Warfarin Sodium | Warfarin Sodium | 41 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 39 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 38 | 11 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 38 | 22 |
| Glipizide Er | Glipizide | 38 | 11 |
| Ibuprofen | Ibuprofen | 37 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 37 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 36 | 18 |
| Gemtesa | Vibegron | 36 | suppressed |
| Lovastatin | Lovastatin | 35 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 34 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 34 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 34 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 33 | 13 |
| Sucralfate | Sucralfate | 33 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 33 | suppressed |
| Trulicity | Dulaglutide | 33 | suppressed |
| Clonazepam | Clonazepam | 32 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 31 | 14 |
| Ondansetron Hcl | Ondansetron Hcl | 31 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 31 | 14 |
| Meclizine Hcl | Meclizine Hcl | 30 | suppressed |
| Nifedipine Er | Nifedipine | 30 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 30 | 12 |
| Xifaxan | Rifaximin | 30 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 29 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 29 | 13 |
| Myrbetriq | Mirabegron | 29 | suppressed |
| Nitroglycerin | Nitroglycerin | 29 | 17 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 29 | suppressed |
| Clotrimazole | Clotrimazole | 28 | 17 |
| Bupropion Xl | Bupropion Hcl | 27 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 27 | 11 |
| Enalapril Maleate | Enalapril Maleate | 26 | suppressed |
| Gemfibrozil | Gemfibrozil | 26 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 26 | 11 |
| Torsemide | Torsemide | 26 | suppressed |
| Atenolol | Atenolol | 25 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 25 | 12 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 25 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 25 | suppressed |
| Carisoprodol | Carisoprodol | 24 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 24 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 23 | suppressed |
| Lacosamide | Lacosamide | 23 | suppressed |
| Nystatin | Nystatin | 22 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 22 | suppressed |
| Digoxin | Digoxin | 21 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 21 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 21 | suppressed |
| Synthroid | Levothyroxine Sodium | 21 | suppressed |
| Linzess | Linaclotide | 20 | suppressed |
| Ramipril | Ramipril | 20 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 19 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 19 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 19 | suppressed |
| Januvia | Sitagliptin Phosphate | 19 | suppressed |
| Baclofen | Baclofen | 18 | suppressed |
| Ketoconazole | Ketoconazole | 18 | 11 |
| Oxycodone Hcl | Oxycodone Hcl | 18 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 18 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 17 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 17 | suppressed |
| Mounjaro | Tirzepatide | 17 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 17 | 16 |
| Ranolazine Er | Ranolazine | 17 | suppressed |
| Constulose | Lactulose | 16 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 16 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 16 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 15 | suppressed |
| Lorazepam | Lorazepam | 15 | suppressed |
| Fenofibrate | Fenofibrate | 14 | suppressed |
| Lactulose | Lactulose | 14 | suppressed |
| Memantine Hcl | Memantine Hcl | 14 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 14 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 14 | suppressed |
| Topiramate | Topiramate | 14 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Budesonide | Budesonide | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Eszopiclone | Eszopiclone | 13 | suppressed |
| Glimepiride | Glimepiride | 13 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 13 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Loperamide | Loperamide Hcl | 13 | suppressed |
| Lumigan | Bimatoprost | 13 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 12 | suppressed |
| Levetiracetam | Levetiracetam | 12 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 12 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 12 | suppressed |
| Metronidazole | Metronidazole | 12 | suppressed |
| Oxycontin | Oxycodone Hcl | 12 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 12 | suppressed |
| Xarelto | Rivaroxaban | 12 | suppressed |
| Diazepam | Diazepam | 11 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
| Valsartan | Valsartan | 11 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $35.58 · 2 records | Abbott Laboratories | FREESTYLE LIBRE 3, The Cologuard Plus Collection Kit | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error